胃肝样腺癌诊疗现状及进展

doi:10.11904/j.issn.1002-3070.2017.01.011

Abstract

Abstract: This paper mainly introduces a rare special subtype of gastric cancer,the stomach hepatoid adenocarcinoma.This kind of adenocarcinoma in pathogenesis,pathology,treatment and prognosis has great difference from traditional stomach cancer.Because it has both characteristics of gastric carcinoma and hepatocellular carcinoma,and is easily to result in missed diagnosis and misdiagnosis in clinic.It is necessary for us to distinguish hepatoid adenocarcinoma of the stomach and gastric carcinoma.We may further improve the diagnosis rate of hepatoid adenocarcinoma of the stomach,and reduce its mortality rate,prolong the survival period.

Key words: Gastric cancer, Hepatoid adenocaecinoma of the stomach, Treatment

CLC Number:

R735.2

LI Rudong, HOU Jiachen, CUI Xiaohan, WANG Xvdong. Progress in diagnosis and treatment of stomach hepatoid adenocaecinoma[J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(1): 53-56.

References

1 Gao YB,Zhang DF,Jin XL,et al.Preliminary study on the clinical and pathological relevance of gastric hepatoid adenocarcinoma[J].J Digest Dis,2007,8(1):23-28.
2 Ishikura H,Fukasawa Y,Ogasawara K,et al.An AFP‐producing gastric carcinoma with features of hepatic differentiation.A case report[J].Cancer,1985,56(4):840-848.
3 Nagai E,Ueyama T,Yao T,et al.Hepatoid adenocarcinoma of the stomach.A clinicopathologic and immunohistochemical analysis[J].Cancer,1993,72(6):1827-1835.
4 Su JS,Chen YT,Wang RC,et al.Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma:a literature review[J].World J Gastroentero,2013,19(3):321-327.
5 Ishikura H,Kishimoto T,Andachi H,et al.Gastrointestinal hepatoid adenocarcinoma:venous permeation and mimicry of hepatocellular carcinoma,a report of four cases[J].Histopathology,1997,31(1):47-54.
6 姚鲁田,徐惠绵.胃肝样腺癌的临床特征与预后[J].中华胃肠外科杂志,2014,17(2):196-200.
7 Kodama T,Kameya T,Hirota T,et al.Production of alpha‐fetoprotein,normal serum proteins,and human chorionic gonadotropin in stomach cancer:Histologic and immunohistochemical analyses of 35 cases[J].Cancer,1981,48(7):1647-1655.
8 茅翔,罗奋,陈宗祐,等.提高对胃肝样腺癌和产甲胎蛋白胃癌的认识[J].中华肿瘤杂志,2015,37(6):401-403.
9 Morinaga S,Takahashi Y.Primary hepatocellular carcinoma and hepatoid adenocarcinoma of the stomach with liver metastasis:an unusual association[J].Jpn J Clin Oncol,1996,26(4):258-263.
10 Hishinuma M,Ohashi KI,Yamauchi N,et al.Hepatocellular oncofetal protein,glypican 3 is a sensitive marker for α‐fetoprotein‐producing gastric carcinoma[J].Histopathology,2006,49(5):479-486.
11 Inagawa S,Shimazaki J,Hori M,et al.Hepatoid adenocarcinoma of the stomach[J].Gastric Cancer,2001,4(1):43-52.
12 Terracciano LM,Glatz K,Mhawech P,et al.Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma:an immunohistochemical and molecular study of eight cases[J].Am J Surg Pathol,2003,27(10):1302-1312.
13 Akiyama S,Tamura G,Endoh Y,et al.Histogenesis of hepatoid adenocarcinoma of the stomach:molecular evidence of identical origin with coexistent tubular adenocarcinoma[J].Int J Cancer,2003,106(4):510-515.
14 Thamboo TP,Wee A.Hep Par 1 expression in carcinoma of the cervix:implications for diagnosis and prognosis[J].J Clin Pathol,2004,57(1):48-53.
15 Plaza JA,Vitellas K,Frankel WL.Hepatoid adenocarcinoma of the stomach[J].Ann Diagn Pathol,2004,8(3):137-141.
16 Kochi M,Fujii M,Kaiga T,et al.FLEP chemotherapy for α-fetoprotein-producing gastric cancer[J].Oncology,2004,66(6):445-449.
17 Takeyama H,Sawai H,Wakasugi T,et al.Successful paclitaxel-based chemotherapy for an alpha-fetoprotein-producing gastric cancer patient with multiple liver metastases[J].World J Surg Oncol,2007,5(1):1.
18 周少飞,常成,苗蕾,等.胃肝样腺癌八例临床分析[J].中华胃肠外科杂志,2019,19(3):341-342.
19 Liu X,Cheng Y,Sheng W,et al.Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach[J].Am J Surg Pathol,2010,34(10):1465-1471.
20 Chun H,Kwon SJ.Clinicopathological characteristics of alpha-fetoprotein-producing gastric cancer[J].J Gastric Cancer,2011,11(1):23-30.
21 Zhang JF,Shi SS,Shao YF,et al.Clinicopathological and prognostic features of hepatoid adenocarcinoma of the stomach[J].Chinese Med J-Peking,2011,124(10):1470-1476.

[1]	QIN Wen,ZHAO Nannan,HAN Yonghuan,XU Yajun. Expression of ZNF436 in gastric cancer and its effect on the migration and invasion of gastric cancer cells by WNT/β-catenin [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 222-227.
[2]	MENG Hai,DU Guanxiang,ZHU Liling,TANG Qiyun. The expression of WEE1 in gastric cancer and its influence on prognosis of patients [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 239-243.
[3]	LIU Jiayin,YAN Feihu,ZHANG Yanqiao. Genetic susceptibility of gastric cancer with single nucleotide polymorphisms(SNPs)of apoptotic genes - caspase-3 and caspase-7 [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(3): 250-255.
[4]	FANG Lin, LIU Chao, ZHANG Chunhui, ZHANG Yanqiao. Research status and treatment strategies of maintenance therapy for metastatic colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 173-178.
[5]	BAI Yuxian, MA Zhongjuan, SU Yingling, MU Anguo, XIE Rui. Research on methylation of FHIT,hMLH1,p16,RAR-beta,Reprimo and TIMP3 genes in gastric cancer patients [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 8-13.
[6]	ZHANG Fengchun, JIANG Ying, LIU Zhaonan, YAN Ningning, CUI Hongquan, XU Yingchun. Prognostic significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in systemic inflammation-related indicators in gastric cancer patients after radical resection [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 34-39.
[7]	ZHANG Bao, ZHENG Zhichao. Research progress in lymph nodes dissection of advanced gastric cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 78-81.
[8]	XING Zhichao, MAI Wei. Research progress on potential targets of liposarcoma [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(1): 82-86.
[9]	TANG Shuli, HE Kuangbang, ZHANG Chunhui, CHENG Jianan, ZHANG Yanqiao. Expression of miR-320a and CYLD in gastric cancer and its relationship with clinicopathological characteristics and prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 538-544.
[10]	TIAN Yang, WU Huaxing. Clinical application of ultra-fine nasal endoscopy in digestive tract stenosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 550-554.
[11]	YI Qingting, ZHANG Hongjun, JIANG Tao, FU Jialei, HUA Mingtao. Reversal effect and mechanism of polyene phosphatidylcholine on oxaliplatin resistance of gastric cancer cells in a nude mouse model [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 385-390.
[12]	WANG Yuan, SUN Yihua. Advance in the role of β-catenin in soft tissue tumors [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 455-459.
[13]	ZHANG Li,FANG Kewei,YUE Xi,WANG Hong,YANG Hanfeng,XU Xiaoxue. Research progress of cryoablation for bone metastases [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 353-356.
[14]	LI Lin, LI Zhigao. The relationship between metformin and different molecular subtypes of breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 267-270.
[15]	YAO Qiang, WANG Kuan, XUE Yingwei. Expression of SRC1 in gastric cancer and its prognosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 97-102.

Progress in diagnosis and treatment of stomach hepatoid adenocaecinoma

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments